$ATNM news expected 06/20           1) phase 3 trial company exercised hoc interim analysis for SIERRA                   2)combination trial update Actimab-A and Venetoclax                                       
$BMY $PFE $BMRN $SGEN $ABBV $JNJ $MRK $NVS $SNY $GILD $TGTX $TRIL https://t.co/ABEXV7wPQG